Xospata 40 mg/1 (Gilteritinib TABLET) 40 mg/1

Xospata 40 mg tablets contain gilteritinib, a medication used in cancer treatment. This oral tablet is manufactured by Astellas Pharma US, Inc. and is available in a 90-tablet bottle.

Strength

40 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0469-1425-90) / 90 TABLET in 1 BOTTLE

Manufacturer / TM Owner

Astellas Pharma US, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xospata 40 mg tablets are primarily used in the treatment of certain types of cancer. Gilteritinib, the active ingredient, is often prescribed for patients who have specific genetic markers. This medication is part of a broader category of drugs known as targeted therapies, which work by interfering with the growth and spread of cancer cells. Patients and healthcare providers should discuss the specific uses of Xospata 40 mg tablets, including what gilteritinib is used for in individual cases.

Side Effects

Common effects of Xospata 40 mg tablets may include fatigue, nausea, and changes in blood cell counts. Some patients may experience muscle pain, fever, or difficulty breathing. It is important to note that individual responses to gilteritinib can vary, and not everyone will experience these effects. Patients should report any persistent or severe symptoms to their healthcare provider.

Precautions & Warnings

Xospata 40 mg tablets should be handled with care and stored as directed. This medication is intended for oral use only and should be taken exactly as prescribed. Patients should avoid breaking or crushing the tablets unless instructed to do so. It is crucial to follow the storage instructions provided to maintain the effectiveness of gilteritinib. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Xospata 40 mg tablets may interact with certain medications, including those that affect liver enzymes. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect liver function may also interact with gilteritinib. It is important to discuss potential interactions with a healthcare provider to ensure safe and effective use of Xospata 40 mg tablets.

Frequently Asked Questions

Xospata 40 mg tablets are used in the treatment of certain types of cancer, often in patients with specific genetic markers.

Xospata 40 mg tablets should be taken orally, exactly as prescribed by your healthcare provider.

Common side effects may include fatigue, nausea, and changes in blood cell counts. Always consult your healthcare provider for personalized advice.

It is important to discuss alcohol consumption with your healthcare provider, as it may interact with gilteritinib.

Store Xospata 40 mg tablets as directed on the packaging or by your healthcare provider to maintain their effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.